Search PDMR transactions

Notifier
Name of person with notification obligation
Bioresund Investeringspartnerskap AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Patrik Renblad
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
SynAct Pharma AB
Issuer´s LEI code
549300RRYIEFEQ72N546
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA SynAct BTA SE0017768963 Subscription 9,127 Quantity 63.00 SEK 25/04/2022 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
SynAct BTA SE0017768963 Subscription 25/04/2022 Outside a trading venue 9,127 (Quantity) 63.00 SEK
Total: 9,127
<< Back